Abstract
This perspective advocates for the adoption of recently published clinical practice guidelines on identifying and managing cardiometabolic risk after spinal cord injury (SCI). It makes the case for acting now, with the knowledge that we currently have, while continuing to address knowledge gaps with high-quality research studies in this area. Cardiovascular disease is a leading cause of death in people with SCI. Cardiometabolic disease (CMD) and risks are more likely to be overlooked after SCI. Unique SCI-related considerations impact both assessment and management of cardiometabolic risk. Risk factors and components of CMD including obesity, impaired glucose tolerance/insulin resistance, dyslipidemia, and hypertension should be evaluated and managed to optimize the cardiometabolic health of this population. While it would be optimal to base all care on high-quality evidence-based research, its absence should not be an excuse for inaction. Applying what is currently known and filling the research gaps with empirical recommendations based on clinical rationale and expert consensus is both appropriate and necessary till more definitive SCI-specific evidence becomes available.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Nash MS, Groah SL, Gater D, Dyson-Hudson TA, Lieberman JA, Myers J. et al. Identification and Management of Cardiometabolic Risk after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers. Top Spinal Cord Inj Rehabil. 2018;24:379–423.
Chopra AS, Miyatani M, Craven BC. Cardiovascular disease risk in individuals with chronic spinal cord injury: prevalence of untreated risk factors and poor adherence to treatment guidelines. J Spinal Cord Med. 2018;41:2–9.
Cragg JJ, Noonan VK, Krassioukov A, Borisoff J. Cardiovascular disease and spinal cord injury: results from a national population health survey. Neurology. 2013;81:723–8.
Sabharwal S. Cardiovascular and autonomic consequences: ischemic heart disease. In: Sabharwal S (ed). Essentials of spinal cord medicine. New York, NY: Demos Medical Publishing; 2014; p 271–7.
Phillips AA, Krassioukov AV. Contemporary cardiovascular concerns after spinal cord injury: mechanisms, maladaptations, and management. J Neurotrauma. 2015;32:1927–42.
Bauman WA, Korsten MA, Radulovic M, Schilero GJ, Wecht JM, Spungen AM. 31st g. Heiner sell lectureship: secondary medical consequences of spinal cord injury. Top Spinal Cord Inj Rehabil. 2012;18:354–78.
Bauman WA, Spungen AM. Carbohydrate and lipid metabolism in chronic spinal cord injury. J Spinal Cord Med. 2001;24:266–77.
Cragg JJ, Noonan VK, Dvorak M, Krassioukov A, Mancini GB, Borisoff JF. Spinal cord injury and type 2 diabetes: results from a population health survey. Neurology. 2013;81:1864–8.
Nash MS, Tractenberg RE, Mendez AJ, David M, Ljungberg IH, Tinsley EA, et al. Cardiometabolic syndrome in people with spinal cord injury/disease: guideline-derived and nonguideline risk components in a pooled sample. Arch Phys Med Rehabil. 2016;97:1696–705.
Bauman WA, Kahn NN, Grimm DR, Spungen AM. Risk factors for atherogenesis and cardiovascular autonomic function in persons with spinal cord injury. Spinal Cord. 1999;37:601–16.
Warburton DE, Eng JJ, Krassioukov A, Sproule S. Cardiovascular health and exercise rehabilitation in spinal cord injury. Top Spinal Cord Inj Rehabil. 2007;13:98–122.
Wilt TJ, Carlson KF, Goldish GD, MacDonald R, Niewoehner C, Rutks I et al. Carbohydrate and lipid disorders and relevant considerations in persons with spinal cord injury. Evid Rep Technol Assess Full Rep. 2008;163:1–95.
LaVela SL, Evans CT, Prohaska TR, Miskevics S, Ganesh SP, Weaver FM. Males aging with a spinal cord injury: prevalence of cardiovascular and metabolic conditions. Arch Phys Med Rehabil. 2012;93:90–5.
Selassie A, Snipe L, Focht KL, Welldaregay W. Baseline prevalence of heart diseases, hypertension, diabetes, and obesity in persons with acute traumatic spinal cord injury: potential threats in the recovery trajectory. Top Spinal Cord Inj Rehabil. 2013;19:172–82.
Wahman K, Nash MS, Lewis JE, Seiger A, Levi R. Increased cardiovascular disease risk in Swedish persons with paraplegia: the Stockholm spinal cord injury study. J Rehabil Med. 2010;42:489–92.
Hitzig SL, Tonack M, Campbell KA, McGillivray CF, Boschen KA, Richards K, et al. Secondary health complications in an aging Canadian spinal cord injury sample. Am J Phys Med Rehabil. 2008;87:545–55.
Soden RJ, Walsh J, Middleton JW, Craven ML, Rutkowski SB, Yeo JD. Causes of death after spinal cord injury. Spinal Cord. 2000;38:604–10.
Garshick E, Kelley A, Cohen SA, Garrison A, Tun CG, Gagnon D, et al. A prospective assessment of mortality in chronic spinal cord injury. Spinal Cord. 2005;43:408–16.
Kressler J, Cowan RE, Bigford GE, Nash MS. Reducing cardiometabolic disease in spinal cord injury. Phys Med Rehabil Clin N Am. 2014;25:573–604.viii.
Jensen MP, Molton IR, Groah SL, Campbell ML, Charlifue S, Chiodo A, et al. Secondary health conditions in individuals aging with SCI: terminology, concepts and analytic approaches. Spinal Cord. 2012;50:373–8.
Libin A, Tinsley EA, Nash MS, Mendez AJ, Burns P, Elrod M, et al. Cardiometabolic risk clustering in spinal cord injury: results of exploratory factor analysis. Top Spinal Cord Inj Rehabil. 2013;19:183–94.
Walker WC, Khokhar MS. Silent cardiac ischemia in cervical spinal cord injury: case study. Arch Phys Med Rehabil. 1992;73:91–4.
Sanford P, Sabharwal S. Diagnosis of myocardial infarction in a patient with complete tetraplegia. J Spinal Cord Med. 2000;23(Suppl 1):47.
Stiens SA, Johnson MC, Lyman PJ. Cardiac rehabilitation in patients with spinal cord injuries. In: Halar EM (ed). Cardiac rehabilitation: Part II. Phys Med Rehabil Clin North Am. 1995;6:263–96.
Bauman WA, Raza M, Spungen AM, Machac J. Cardiac stress testing with thallium-201 imaging reveals silent ischemia in individuals with paraplegia. Arch Phys Med Rehabil. 1994;75:946–50.
Lee CS, Lu YH, Lee ST, Lin CC, Ding HJ. Evaluating the prevalence of silent coronary artery disease in asymptomatic patients with spinal cord injury. Int Heart J. 2006;47:325–30.
Gater DR Jr. Obesity after spinal cord injury. Phys Med Rehabil Clin N Am. 2007;18:333–51.vii.
Teasell RW, Arnold JM, Krassioukov A, Delaney GA. Cardiovascular consequences of loss of supraspinal control of the sympathetic nervous system after spinal cord injury. Arch Phys Med Rehabil. 2000;81:506–16.
Figoni SF. Perspectives on cardiovascular fitness and SCI. J Am Paraplegia Soc. 1990;13:63–71.
Figoni SF. Exercise responses and quadriplegia. Med Sci Sports Exerc. 1993;25:433–41.
Coutts KD, Rhodes EC, McKenzie DC. Maximal exercise responses of tetraplegics and paraplegics. J Appl Physiol Respir Environ Exerc Physiol. 1983;55:479–82.
Peiffer SC, Blust P, Leyson JF. Nutritional assessment of the spinal cord injured patient. J Am Diet Assoc. 1981;78:501–5.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596–e646.
American Diabetes Association. Standards of Medical Care in Diabetes-2018. Clin Diabetes. 2018;36:14–37.
Buchholz AC, Pencharz PB. Energy expenditure in chronic spinal cord injury. Curr Opin Clin Nutr Metab Care. 2004;7:635–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that he has no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sabharwal, S. Addressing cardiometabolic risk in adults with spinal cord injury: acting now despite knowledge gaps. Spinal Cord Ser Cases 5, 96 (2019). https://doi.org/10.1038/s41394-019-0241-5
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41394-019-0241-5
This article is cited by
-
Meglumine cyclic adenylate improves cardiovascular hemodynamics and motor-function in a rat model of acute T4 thoracic spinal cord injury
Spinal Cord (2023)
-
Recent Updates in Nutrition After Spinal Cord Injury: 2015 Through 2021
Current Physical Medicine and Rehabilitation Reports (2022)
-
Physical activity and cardiometabolic risk factors in individuals with spinal cord injury: a systematic review and meta-analysis
European Journal of Epidemiology (2022)
-
Multidimensional review of cognitive impairment after spinal cord injury
Acta Neurologica Belgica (2021)
-
Point: Counterpoint synopsis of cardiometabolic risk after spinal cord injury
Spinal Cord Series and Cases (2019)
